FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060483733> ?p ?o ?g. }

• W2060483733 endingPage "3542" @default.
• W2060483733 startingPage "3531" @default.
• W2060483733 abstract "The mechanistic link between Janus kinase (JAK) signaling and structural damage to arthritic joints in rheumatoid arthritis (RA) is poorly understood. This study was undertaken to investigate how selective inhibition of JAK with tofacitinib (CP-690,550) affects osteoclast-mediated bone resorption in a rat adjuvant-induced arthritis (AIA) model, as well as human T lymphocyte RANKL production and human osteoclast differentiation and function.Hind paw edema, inflammatory cell infiltration, and osteoclast-mediated bone resorption in rat AIA were assessed using plethysmography, histopathologic analysis, and immunohistochemistry; plasma and hind paw tissue levels of cytokines and chemokines (including RANKL) were also assessed. In vitro RANKL production by activated human T lymphocytes was evaluated by immunoassay, while human osteoclast differentiation and function were assessed via quantitative tartrate-resistant acid phosphatase staining and degradation of human bone collagen, respectively.Edema, inflammation, and osteoclast-mediated bone resorption in rats with AIA were dramatically reduced after 7 days of treatment with the JAK inhibitor, which correlated with reduced numbers of CD68/ED-1+, CD3+, and RANKL+ cells in the paws; interleukin-6 (transcript and protein) levels were rapidly reduced in paw tissue within 4 hours of the first dose, whereas it took 4-7 days of therapy for RANKL levels to decrease. Tofacitinib did not impact human osteoclast differentiation or function, but did decrease human T lymphocyte RANKL production in a concentration-dependent manner.These results suggest that the JAK inhibitor tofacitinib suppresses osteoclast-mediated structural damage to arthritic joints, and this effect is secondary to decreased RANKL production." @default.
• W2060483733 created "2016-06-24" @default.
• W2060483733 creator A5000302135 @default.
• W2060483733 creator A5008523968 @default.
• W2060483733 creator A5010781139 @default.
• W2060483733 creator A5011247686 @default.
• W2060483733 creator A5031349668 @default.
• W2060483733 creator A5032149939 @default.
• W2060483733 creator A5032746200 @default.
• W2060483733 creator A5034718964 @default.
• W2060483733 creator A5036305258 @default.
• W2060483733 creator A5042590198 @default.
• W2060483733 creator A5049559220 @default.
• W2060483733 creator A5051985402 @default.
• W2060483733 creator A5054024407 @default.
• W2060483733 creator A5062230930 @default.
• W2060483733 creator A5067028177 @default.
• W2060483733 creator A5073312039 @default.
• W2060483733 creator A5075441975 @default.
• W2060483733 creator A5083202033 @default.
• W2060483733 creator A5083798885 @default.
• W2060483733 creator A5084129668 @default.
• W2060483733 creator A5086210412 @default.
• W2060483733 date "2012-10-27" @default.
• W2060483733 modified "2023-10-17" @default.
• W2060483733 title "JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production" @default.
• W2060483733 cites W1555276708 @default.
• W2060483733 cites W1639854378 @default.
• W2060483733 cites W1677043489 @default.
• W2060483733 cites W1964423738 @default.
• W2060483733 cites W1967502057 @default.
• W2060483733 cites W1967623383 @default.
• W2060483733 cites W1979239025 @default.
• W2060483733 cites W1995629248 @default.
• W2060483733 cites W2001395916 @default.
• W2060483733 cites W2002782759 @default.
• W2060483733 cites W2015527055 @default.
• W2060483733 cites W2042593266 @default.
• W2060483733 cites W2045441262 @default.
• W2060483733 cites W2050718018 @default.
• W2060483733 cites W2070845911 @default.
• W2060483733 cites W2073842018 @default.
• W2060483733 cites W2075317869 @default.
• W2060483733 cites W2092961174 @default.
• W2060483733 cites W2093624424 @default.
• W2060483733 cites W2100772783 @default.
• W2060483733 cites W2101217991 @default.
• W2060483733 cites W2101460301 @default.
• W2060483733 cites W2103445654 @default.
• W2060483733 cites W2107003864 @default.
• W2060483733 cites W2117926449 @default.
• W2060483733 cites W2119103976 @default.
• W2060483733 cites W2119978797 @default.
• W2060483733 cites W2121219094 @default.
• W2060483733 cites W2125438927 @default.
• W2060483733 cites W2129669029 @default.
• W2060483733 cites W2129948300 @default.
• W2060483733 cites W2132981126 @default.
• W2060483733 cites W2138784254 @default.
• W2060483733 cites W2139996507 @default.
• W2060483733 cites W2148197913 @default.
• W2060483733 cites W2149189075 @default.
• W2060483733 cites W2160005424 @default.
• W2060483733 cites W2164327378 @default.
• W2060483733 doi "https://doi.org/10.1002/art.34649" @default.
• W2060483733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22899318" @default.
• W2060483733 hasPublicationYear "2012" @default.
• W2060483733 type Work @default.
• W2060483733 sameAs 2060483733 @default.
• W2060483733 citedByCount "114" @default.
• W2060483733 countsByYear W20604837332012 @default.
• W2060483733 countsByYear W20604837332013 @default.
• W2060483733 countsByYear W20604837332014 @default.
• W2060483733 countsByYear W20604837332015 @default.
• W2060483733 countsByYear W20604837332016 @default.
• W2060483733 countsByYear W20604837332017 @default.
• W2060483733 countsByYear W20604837332018 @default.
• W2060483733 countsByYear W20604837332019 @default.
• W2060483733 countsByYear W20604837332020 @default.
• W2060483733 countsByYear W20604837332021 @default.
• W2060483733 countsByYear W20604837332022 @default.
• W2060483733 countsByYear W20604837332023 @default.
• W2060483733 crossrefType "journal-article" @default.
• W2060483733 hasAuthorship W2060483733A5000302135 @default.
• W2060483733 hasAuthorship W2060483733A5008523968 @default.
• W2060483733 hasAuthorship W2060483733A5010781139 @default.
• W2060483733 hasAuthorship W2060483733A5011247686 @default.
• W2060483733 hasAuthorship W2060483733A5031349668 @default.
• W2060483733 hasAuthorship W2060483733A5032149939 @default.
• W2060483733 hasAuthorship W2060483733A5032746200 @default.
• W2060483733 hasAuthorship W2060483733A5034718964 @default.
• W2060483733 hasAuthorship W2060483733A5036305258 @default.
• W2060483733 hasAuthorship W2060483733A5042590198 @default.
• W2060483733 hasAuthorship W2060483733A5049559220 @default.
• W2060483733 hasAuthorship W2060483733A5051985402 @default.
• W2060483733 hasAuthorship W2060483733A5054024407 @default.
• W2060483733 hasAuthorship W2060483733A5062230930 @default.
• W2060483733 hasAuthorship W2060483733A5067028177 @default.

• next